| Joanne Berthelsen Lcsw Llc | |
|
830 Armour Rd Ste 2 Oconomowoc WI 53066-3959 | |
| (262) 235-2350 | |
| (235) 804-8132 |
| Full Name | Joanne Berthelsen Lcsw Llc |
|---|---|
| Speciality | Social Worker |
| Location | 830 Armour Rd Ste 2, Oconomowoc, Wisconsin |
| Authorized Official Name and Position | Joanne Berthelsen (OWNER/PROVIDER) |
| Authorized Official Contact | 2622352350 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Joanne Berthelsen Lcsw Llc 830 Armour Rd Ste 2 Oconomowoc WI 53066-3959 Ph: (262) 235-2350 | Joanne Berthelsen Lcsw Llc 830 Armour Rd Ste 2 Oconomowoc WI 53066-3959 Ph: (262) 235-2350 |
| NPI Number | 1124657721 |
|---|---|
| Provider Enumeration Date | 04/06/2020 |
| Last Update Date | 04/06/2020 |
| Certification Date | 04/06/2020 |
| Medicare PECOS PAC ID | 7911338066 |
|---|---|
| Medicare Enrollment ID | O20200506000375 |
News Archive
Parkinson's disease is marked by the abnormal accumulation of α-synuclein and the early loss of dopamine neurons in the substantia nigra region of the brain. A polymorphism in the promotor of α-synuclein gene known as NACP-Rep1 has been implicated as a risk factor for the disease.
The US Food and Drug Administration (FDA) has approved Zortress® (everolimus) oral tablets for the prevention of rejection of kidney transplants in adult patients at low-to-moderate immunologic risk. Zortress is to be given in combination with reduced doses of the calcineurin inhibitor (CNI) cyclosporine, as well as basiliximab and corticosteroids.
Following a negative complete colonoscopy, those who had their colonoscopies at a hospital and had their procedures performed by a non-gastroenterologist may be at a significantly increased risk of developing subsequent colorectal cancer (CRC), according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute.
AMAG Pharmaceuticals, Inc. today announced that the company has reached agreement with the U.S. Food and Drug Administration (FDA) regarding an update to the product label for Feraheme (ferumoxytol) Injection for intravenous (IV) use.
Toddler speech delays and temper tantrums have long been assumed to go hand in hand, but no large-scale research had successfully backed up that assumption with data.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124657721 | NPI | - | NPPES |
| 100071305 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | (* (Not Available)) | Secondary |
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Provider Name | Joanne M Berthelsen |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1831614049 PECOS PAC ID: 2062788078 Enrollment ID: I20171018003594 |
News Archive
Parkinson's disease is marked by the abnormal accumulation of α-synuclein and the early loss of dopamine neurons in the substantia nigra region of the brain. A polymorphism in the promotor of α-synuclein gene known as NACP-Rep1 has been implicated as a risk factor for the disease.
The US Food and Drug Administration (FDA) has approved Zortress® (everolimus) oral tablets for the prevention of rejection of kidney transplants in adult patients at low-to-moderate immunologic risk. Zortress is to be given in combination with reduced doses of the calcineurin inhibitor (CNI) cyclosporine, as well as basiliximab and corticosteroids.
Following a negative complete colonoscopy, those who had their colonoscopies at a hospital and had their procedures performed by a non-gastroenterologist may be at a significantly increased risk of developing subsequent colorectal cancer (CRC), according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute.
AMAG Pharmaceuticals, Inc. today announced that the company has reached agreement with the U.S. Food and Drug Administration (FDA) regarding an update to the product label for Feraheme (ferumoxytol) Injection for intravenous (IV) use.
Toddler speech delays and temper tantrums have long been assumed to go hand in hand, but no large-scale research had successfully backed up that assumption with data.
› Verified 1 days ago
News Archive
Parkinson's disease is marked by the abnormal accumulation of α-synuclein and the early loss of dopamine neurons in the substantia nigra region of the brain. A polymorphism in the promotor of α-synuclein gene known as NACP-Rep1 has been implicated as a risk factor for the disease.
The US Food and Drug Administration (FDA) has approved Zortress® (everolimus) oral tablets for the prevention of rejection of kidney transplants in adult patients at low-to-moderate immunologic risk. Zortress is to be given in combination with reduced doses of the calcineurin inhibitor (CNI) cyclosporine, as well as basiliximab and corticosteroids.
Following a negative complete colonoscopy, those who had their colonoscopies at a hospital and had their procedures performed by a non-gastroenterologist may be at a significantly increased risk of developing subsequent colorectal cancer (CRC), according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute.
AMAG Pharmaceuticals, Inc. today announced that the company has reached agreement with the U.S. Food and Drug Administration (FDA) regarding an update to the product label for Feraheme (ferumoxytol) Injection for intravenous (IV) use.
Toddler speech delays and temper tantrums have long been assumed to go hand in hand, but no large-scale research had successfully backed up that assumption with data.
› Verified 1 days ago
Mark H Rossing Mdsc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 888 Thackeray Trl, Suite 211, Oconomowoc, WI 53066 Phone: 262-567-1122 Fax: 262-567-1481 | |
South Street Clinic Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 416 W South St, Oconomowoc, WI 53066 Phone: 262-567-7673 Fax: 262-567-3097 | |
Secure Beginnings, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: N52w35634 W Lake Dr, Oconomowoc, WI 53066 Phone: 262-901-5881 | |
A New Day Psychological Services Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 970 S Silver Lake St, Suite 103, Oconomowoc, WI 53066 Phone: 262-567-7900 Fax: 262-567-7908 | |
Bethany Christian Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1331 Capitol Dr, Oconomowoc, WI 53066 Phone: 262-547-6557 Fax: 262-547-3644 | |
Roots Counseling And Consulting, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: W340n8809 Townline Rd, Oconomowoc, WI 53066 Phone: 262-442-8433 |